On November 16, 2025, Oramed Pharmaceuticals Inc. declared a dividend of one common stock purchase right for each share outstanding, payable on November 27, 2025, allowing holders to purchase shares at $10.00 each. This event is significant as it introduces a strategic measure to protect shareholders against potential takeovers and market fluctuations.